FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315689135> ?p ?o ?g. }

• W2315689135 endingPage "A883" @default.
• W2315689135 startingPage "A883.3" @default.
• W2315689135 abstract "<h3>Background</h3> Weight could be expected to affect the response to biological therapies by simply reducing the mg/Kg dose in fixed dose regimens. Furthermore, adipose tissue produces a variety of pro-inflammatory cytokines (as TNFa, IL-6, IL- 1) whose role in Rheumatoid Arthritis (RA) activity, remains unclear. <h3>Objectives</h3> The purpose of this study was to determine whether body mass index (BMI) is related with response to the biologic therapy adjusted to the weight (tocilizumab, infliximab) in RA patients. <h3>Methods</h3> Patients with RA followed in our day-hospital and registered in BioReportAR who had complete information of baseline and 12^th week visit were included. Only patients with intravenously weight-adjusted therapy were considered. The body mass index (BMI) at baseline was calculated. Sociodemoraphic and clinical data were collected using data from the BioReportAR. Spearman correlation coefficient was used to analyse correlation between BMI and disease activity at baseline and its change after 12 weeks. Comparison between BMI categories was performed using Kruskal-Wallis test. p-values <0,05 were considered as statistically significant. <h3>Results</h3> 45 patients were included (86,7% women, mean disease duration 12,93±10,69 years, mean age 57,11±11,0 years), 20 receiving tocilizumab and 25 infliximab. The BMI mean was 25,55±3,92 kg/m², and at baseline the mean DAS28 was 3,06±1,33. No correlation between BMI and baseline DAS28 (r= -0,158; p=0,519), change DAS28 (r= -0,207; p= 0,177) and individual parameters of DAS calculation were observed. When we compared change in DAS 28 between BMI categories (BMI£25 kg/m² and >25 kg/m²) it didn’t show difference (p=0.607). <h3>Conclusions</h3> This study is the first that correlates tocilizumab and BMI. In this study, BMI was not associated with disease activity or response to tocilizumab or infliximab therapy. These negative results might be at least partially explained by the low number of patients with BMI ³30 kg/m² (only 6) or by using BMI as unique marker of adipose tissue. <h3>Disclosure of Interest</h3> None Declared" @default.
• W2315689135 created "2016-06-24" @default.
• W2315689135 creator A5019768612 @default.
• W2315689135 creator A5026473621 @default.
• W2315689135 creator A5059601670 @default.
• W2315689135 creator A5078368361 @default.
• W2315689135 date "2013-06-01" @default.
• W2315689135 modified "2023-09-24" @default.
• W2315689135 title "AB0315 Is the efficacy of biologic therapeutic in rheumatoid arthritis is affected by body mass index?" @default.
• W2315689135 doi "https://doi.org/10.1136/annrheumdis-2013-eular.2637" @default.
• W2315689135 hasPublicationYear "2013" @default.
• W2315689135 type Work @default.
• W2315689135 sameAs 2315689135 @default.
• W2315689135 citedByCount "0" @default.
• W2315689135 crossrefType "journal-article" @default.
• W2315689135 hasAuthorship W2315689135A5019768612 @default.
• W2315689135 hasAuthorship W2315689135A5026473621 @default.
• W2315689135 hasAuthorship W2315689135A5059601670 @default.
• W2315689135 hasAuthorship W2315689135A5078368361 @default.
• W2315689135 hasConcept C126322002 @default.
• W2315689135 hasConcept C17991360 @default.
• W2315689135 hasConcept C2777077863 @default.
• W2315689135 hasConcept C2777138892 @default.
• W2315689135 hasConcept C2777178219 @default.
• W2315689135 hasConcept C2777575956 @default.
• W2315689135 hasConcept C2780221984 @default.
• W2315689135 hasConcept C3017894415 @default.
• W2315689135 hasConcept C511355011 @default.
• W2315689135 hasConcept C544821477 @default.
• W2315689135 hasConcept C71924100 @default.
• W2315689135 hasConcept C90924648 @default.
• W2315689135 hasConceptScore W2315689135C126322002 @default.
• W2315689135 hasConceptScore W2315689135C17991360 @default.
• W2315689135 hasConceptScore W2315689135C2777077863 @default.
• W2315689135 hasConceptScore W2315689135C2777138892 @default.
• W2315689135 hasConceptScore W2315689135C2777178219 @default.
• W2315689135 hasConceptScore W2315689135C2777575956 @default.
• W2315689135 hasConceptScore W2315689135C2780221984 @default.
• W2315689135 hasConceptScore W2315689135C3017894415 @default.
• W2315689135 hasConceptScore W2315689135C511355011 @default.
• W2315689135 hasConceptScore W2315689135C544821477 @default.
• W2315689135 hasConceptScore W2315689135C71924100 @default.
• W2315689135 hasConceptScore W2315689135C90924648 @default.
• W2315689135 hasIssue "Suppl 3" @default.
• W2315689135 hasLocation W23156891351 @default.
• W2315689135 hasOpenAccess W2315689135 @default.
• W2315689135 hasPrimaryLocation W23156891351 @default.
• W2315689135 hasRelatedWork W2108792058 @default.
• W2315689135 hasRelatedWork W2111317550 @default.
• W2315689135 hasRelatedWork W2145046614 @default.
• W2315689135 hasRelatedWork W2239139857 @default.
• W2315689135 hasRelatedWork W2313136086 @default.
• W2315689135 hasRelatedWork W2317799447 @default.
• W2315689135 hasRelatedWork W2318122589 @default.
• W2315689135 hasRelatedWork W2320950754 @default.
• W2315689135 hasRelatedWork W2326711255 @default.
• W2315689135 hasRelatedWork W2326713497 @default.
• W2315689135 hasRelatedWork W2327884856 @default.
• W2315689135 hasRelatedWork W2408759624 @default.
• W2315689135 hasRelatedWork W2551931721 @default.
• W2315689135 hasRelatedWork W2561613017 @default.
• W2315689135 hasRelatedWork W2754650263 @default.
• W2315689135 hasRelatedWork W2903319434 @default.
• W2315689135 hasRelatedWork W2996956134 @default.
• W2315689135 hasRelatedWork W3118365478 @default.
• W2315689135 hasRelatedWork W3200456282 @default.
• W2315689135 hasRelatedWork W893036420 @default.
• W2315689135 hasVolume "72" @default.
• W2315689135 isParatext "false" @default.
• W2315689135 isRetracted "false" @default.
• W2315689135 magId "2315689135" @default.
• W2315689135 workType "article" @default.